Watching Astrana Health; Glass House Research Issues Report On Co Stating It Holds A Short Position
https://www.glasshouseresearch.com/uploads/8/9/6/9/89690703/asth_final_-_copy.pdf
Stocks · News reference
Astrana Health Q2 EPS $0.40 Beats $0.34 Estimate, Sales $972.520M Miss $985.716M Estimate
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.34 by 17.65 percent. This is a 110.53 percent increase over earnings of $0.19 per share from
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Oppenheimer Initiates Coverage On Astrana Health with Outperform Rating, Announces Price Target of $53
Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $53.
8-K filing — Astrana Health, Inc. (ASTH)
Filed: 2026-09-15 AccNo: 0001104659-26-107730 Size: 9 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $47 to $55.